M&G PLC

Position in PFE — Pfizer Inc

CIK 1802539 London, X0

Position in PFE

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$10,080,514

-$5,270,063 QoQ

Shares Held

418,626

-23.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#428

of 2,826 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. PFE ranks #7 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,482,712	$850,011,848
2	BMY	Bristol Myers Squibb Co	5,292,229	$304,938,234
3	ABBV	AbbVie Inc.	579,447	$145,812,043
4	AMGN	Amgen Inc	289,819	$104,949,256
5	MRK	Merck & Co., Inc.	210,965	$27,109,002
6	JNJ	Johnson & Johnson	52,505	$13,334,694
7	PFE	Pfizer Inc This page	418,626	$10,080,514
8	GILD	Gilead Sciences, Inc.	78,527	$9,921,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,080,514	418,626	-23.4%	Shares	Defined	2026-08-06
2026-03-31	$15,350,577	546,673	-5.3%	Shares	Defined	2026-05-13
2025-12-31	$14,371,782	577,180	+5.6%	Shares	Defined	2026-02-12
2025-09-30	$13,924,412	546,484	-13.3%	Shares	Defined	2025-11-07
2025-06-30	$15,282,204	630,454	-13.6%	Shares	Sole	2025-08-08
2025-03-31	$18,500,835	730,104	-8.3%	Shares	Sole	2025-05-13
2024-12-31	$21,132,551	796,553	-0.2%	Shares	Sole	2025-02-11
2024-09-30	$23,106,969	798,444	-1.8%	Shares	Sole	2024-10-31
2024-06-30	$22,759,575	813,423	+14.5%	Shares	Sole	2024-07-16
2024-03-31	$19,707,189	710,169	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.